Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8860603 | 1.00 | TRPV3 (0.34) | TRPV3ALDH1A1CYP2C9ESR2ESR1 | |
| SCHEMBL3437354 | 0.95 | TRPV3 (0.32) | TRPV3ALDH1A1 | |
| SCHEMBL7913623 | 0.95 | CYP2C9 (0.36) | TRPV3ALDH1A1CYP2C9ESR2LMNA | |
| SCHEMBL8015656 | 0.95 | TRPV3 (0.32) | TRPV3ALDH1A1 | |
| SCHEMBL8736434 | 0.95 | TRPV3 (0.32) | TRPV3ALDH1A1 | |
| SCHEMBL8736323 | 0.95 | CYP2C9 (0.36) | TRPV3ALDH1A1CYP2C9ESR2LMNA | |
| SCHEMBL18512507 | 0.95 | TRPV3 (0.32) | TRPV3ALDH1A1 | |
| SCHEMBL8015649 | 0.95 | TRPV3 (0.32) | TRPV3ALDH1A1 | |
| SCHEMBL8734596 | 0.90 | TRPV3 (0.30) | TRPV3 | |
| SCHEMBL8734602 | 0.90 | TRPV3 (0.30) | TRPV3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180119011-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE THEREOF | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2018-05-03 | — | — | US | disclosed |
| US-20180119011-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE THEREOF | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2018-05-03 | — | — | US | disclosed |
| US-20120274888-A1 | OPTICALLY ANISOTROPIC SUBSTANCE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-11-01 | — | — | US | disclosed |
| US-8048496-B2 | Polymerizable liquid crystal compound, liquid crystal composition and polymer | JNC CORPORATION (JP) | 2011-11-01 | — | — | US | disclosed |
| US-20100297367-A1 | OPTICALLY ANISOTROPIC SUBSTANCE | CHISSO CORPORATION (JP) | 2010-11-25 | — | — | US | disclosed |
| US-20100096591-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND POLYMER | CHISSO CORPORATION | 2010-04-22 | — | — | US | disclosed |
| US-5032313-A | Trifluorobenzene derivative and liquid crystal composition containing the same | CHISSO CORPORATION (JP) | 1991-07-16 | — | — | US | disclosed |
| EP-0387032-A1 | Trifluorobenzene derivatives and liquid crystal compositions containing the same | Chisso Corporation (JP) | 1990-09-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100096591-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND POLYMER | PKN1, ZYX, OXER1 | TRPV3 2239/4885ALDH1A1 839/4885CYP2C9 682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.